meta_pixel
Tapesearch Logo
Log in
The Indicator from Planet Money

The opioid business plan

The Indicator from Planet Money

NPR

Business

4.79.5K Ratings

🗓️ 25 January 2022

⏱️ 10 minutes

🧾️ Download transcript

Summary

Insys Therapeutics was an opioid startup that made lots of money for its addictive nasal spray. Today, we hear from Evan Hughes, author of the book Hard Sell: Crime and Punishment at an Opioid Startup, on how the company's carelessness led to its ultimate downfall.

Transcript

Click on a timestamp to play from that location

0:00.0

NPR.

0:11.5

This is the indicator from Planet Money.

0:13.1

I'm Stacey Vannick Smith.

0:14.9

The opioid epidemic has been raging for decades in the US.

0:18.9

Opioid overdoses are now one of the top causes of death among Americans ages 18 to 45.

0:25.0

A bunch of drug companies and doctors have been accused of aggressive marketing and over

0:29.1

prescribing the drug.

0:31.0

And a new book gives us a window into exactly how this happens.

0:35.1

The hard sell.

0:36.3

Crime and punishment at an opioid startup explores one drug maker, a small startup, and looks

0:41.1

at how this company marketed its powerful opioid and became a Wall Street sensation.

0:46.3

And then how the company fell apart and its top executives ended up in jail.

0:51.3

We talk with author Evan Hughes about the business of opioids after the break.

1:01.7

This message comes from NPR, sponsor Fundrise, a platform that makes investing in high-end

1:06.3

real estate easy.

1:07.7

You tell Fundrise your investing goals and Fundrise puts your money into the real estate

1:11.9

deals that are right for you.

1:13.9

Sign up for free at fundrise.com slash NPR.

1:19.1

And Hughes author of the hard sell, thank you for joining us.

1:22.8

So your book centers around this little company incess.

1:26.3

And they had this one drug subsist, which was a liquid opioid sold in a little spray bottle

1:31.3

because she'd sprayed into your mouth.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.